Histology and Cytology IVD Market Update, 2024 provides an in-depth competitive analysis of the histology/cytology market from 2023 to 2028. The forecasted market analysis from 2023 to 2028 is based on demographic trends, new technological developments, innovative products, and global market expansion. This comprehensive review offers insights into the future direction of the histology and cytology IVD market, highlighting the potential for growth and advancements.
Histology and cytology have long been essential components of pathological laboratories, offering critical insights into cells, tissues, and organs. Through histopathological examinations, a variety of diseases, including cancer, can be accurately diagnosed. Physicians rely heavily on pathological information to determine treatment plans and prognoses.
Technological Advancements
Recent technological advancements have significantly enhanced the understanding of tissue and organ structure-function relationships and their link to diseases. Innovations such as digital imaging, quantitative microscopy, precision microscopy, artificial intelligence, and virtual histology are set to revolutionize the histology/cytology industry, improving accuracy and automating workflows.
Market Segmentation
This report exclusively focuses on traditional histology and segments the market into five key areas:
- Traditional Non-PAP Stains
- PAP
- In Situ Hybridization
- Immunohistochemistry
- HPV
Key Market Participants
The report also profiles five leading companies in the market:
- Agilent
- Danaher Corporation
- Hologic
- Illumina
- Roche Diagnostics
Market Data
All market data pertains to the global market at the manufacturers’ level, focusing on manufacturer tests. The base year for data is 2023, with projections for 2028. The report provides compound annual growth rates (CAGRs) for 2023-2028. Additionally, competitive analysis and regional breakdowns for the United States, Europe, Asia-Pacific, and the Rest of the World are included.
